Nitin A Pagedar1, Catherine Chioreso2, Jennifer A Schlichting2, Charles F Lynch2,3, Mary E Charlton2. 1. Department of Otolaryngology - Head and Neck Surgery, University of Iowa, 200 Hawkins Drive, 21200 PFP, Iowa City, IA, 52242, USA. nitin-pagedar@uiowa.edu. 2. Department of Epidemiology, University of Iowa, Iowa City, IA, USA. 3. State Health Registry of Iowa, Iowa City, IA, USA.
Abstract
PURPOSE: Treatment for oropharyngeal cancer (OPC) has changed over the past two decades under multiple influences. We provide a population-based description of the application of radiotherapy, surgery, and chemotherapy to OPC in 1997, 2004, and 2009. METHODS: The National Cancer Institute's Patterns of Care study for OPC included multiple variables not available in the public-use dataset. We identified factors correlating with selection of primary surgery versus radiotherapy with or without chemotherapy (RTC) and analyzed predictors of all-cause mortality. We estimated the frequency of human papillomavirus (HPV) testing. RESULTS: RTC was more common in 2009 than in 1997, and was more commonly applied to Stage IV cases. However, RTC was not an independent risk factor for mortality compared with surgery. HPV status was known in 14% of patients in 2009. CONCLUSIONS: RTC is the most common treatment for OPC, but it may not provide the best outcomes. HPV testing was uncommon in 2009.
PURPOSE: Treatment for oropharyngeal cancer (OPC) has changed over the past two decades under multiple influences. We provide a population-based description of the application of radiotherapy, surgery, and chemotherapy to OPC in 1997, 2004, and 2009. METHODS: The National Cancer Institute's Patterns of Care study for OPC included multiple variables not available in the public-use dataset. We identified factors correlating with selection of primary surgery versus radiotherapy with or without chemotherapy (RTC) and analyzed predictors of all-cause mortality. We estimated the frequency of human papillomavirus (HPV) testing. RESULTS: RTC was more common in 2009 than in 1997, and was more commonly applied to Stage IV cases. However, RTC was not an independent risk factor for mortality compared with surgery. HPV status was known in 14% of patients in 2009. CONCLUSIONS: RTC is the most common treatment for OPC, but it may not provide the best outcomes. HPV testing was uncommon in 2009.
Entities:
Keywords:
Chemoradiotherapy; Human papillomavirus; Oropharyngeal neoplasm; Radiotherapy; Surgery
Authors: G Calais; M Alfonsi; E Bardet; C Sire; T Germain; P Bergerot; B Rhein; J Tortochaux; P Oudinot; P Bertrand Journal: J Natl Cancer Inst Date: 1999-12-15 Impact factor: 13.506
Authors: Joseph Zenga; Michael Wilson; Douglas R Adkins; Hiram A Gay; Bruce H Haughey; Dorina Kallogjeri; Loren S Michel; Randal C Paniello; Jason T Rich; Wade L Thorstad; Brian Nussenbaum Journal: JAMA Otolaryngol Head Neck Surg Date: 2015-12 Impact factor: 6.223
Authors: Erik Liederbach; Carol M Lewis; Katharine Yao; Bruce E Brockstein; Chi-Hsiung Wang; Waseem Lutfi; Mihir K Bhayani Journal: Ann Surg Oncol Date: 2015-04-17 Impact factor: 5.344
Authors: D M Brizel; M E Albers; S R Fisher; R L Scher; W J Richtsmeier; V Hars; S L George; A T Huang; L R Prosnitz Journal: N Engl J Med Date: 1998-06-18 Impact factor: 91.245
Authors: Jennifer A Schlichting; Nitin A Pagedar; Catherine Chioreso; Charles F Lynch; Mary E Charlton Journal: Cancer Causes Control Date: 2019-05-22 Impact factor: 2.506